Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-4423

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-4423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (96f45871 7175 49d8 8374 Dfa2978d38c7 01)

Structural Formula (96f45871 7175 49d8 8374 Dfa2978d38c7 01)
Chemical structure of atorvastatin calcium depicted as a complex molecular diagram showing its organic rings, functional groups, and calcium ion complexation with three water molecules indicated.*
FDA Label Image

Figure1 (96f45871 7175 49d8 8374 Dfa2978d38c7 02)

Figure1 (96f45871 7175 49d8 8374 Dfa2978d38c7 02)
A line graph comparing cumulative incidence (%) over time (years) between Atorvastatin and placebo groups. The graph shows lower cumulative incidence in the Atorvastatin group versus placebo across approximately 3.5 years, with labeled hazard ratio (HR=0.64) and a p-value (0.0005) indicated on the chart.*
FDA Label Image

Figure2 (96f45871 7175 49d8 8374 Dfa2978d38c7 03)

Figure2 (96f45871 7175 49d8 8374 Dfa2978d38c7 03)
A line graph showing the cumulative hazard percentage over time in years (up to 5 years) comparing Placebo (dashed line) and Atorvastatin (solid line). The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentage. The graph illustrates a lower cumulative hazard for Atorvastatin compared to Placebo, with a hazard ratio (HR) of 0.63 (0.48-0.83) and p=0.001.*
FDA Label Image

Figure3 (96f45871 7175 49d8 8374 Dfa2978d38c7 04)

Figure3 (96f45871 7175 49d8 8374 Dfa2978d38c7 04)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time between two Atorvastatin dosages: 10 mg (dotted line) and 80 mg (solid line). The x-axis represents years to the first major cardiovascular endpoint, and the y-axis shows the percentage of subjects. Statistical values HR 0.78 (0.69-0.89) and P=0.0002 are noted.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Atorvastatin Calcium 20 mg oral film-coated tablets, packaged in a quantity of 100. The label includes the NDC number 70518-4423-00, and manufacturer information for LifeStar, Mahwah, NJ, with repackaging by RemedyRepack Inc., Indiana, PA. It specifies storage instructions and dosage should be referred to the insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.